Insider Buying: Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Acquires 1,003 Shares of Stock

Résumé détaillé

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) insider Jeffrey Arcara bought 1,003 shares of the stock in a transaction that occurred on Friday, November 13th. The shares were purchased at an average price of $10.54 per share, for a total transaction of $10,571.62. Following the purchase, the insider owned 4,500 shares in the company, valued at $47,430.